Leaps by Bayer Investor
Leaps is the strategic impact investment unit of Bayer. By accelerating transformative biotechnologies, we aim to shift key paradigms in life science, changing the world for better.
In health, we pursue breakthroughs that could set new standards in medical care, moving from treating symptoms to curing or preventing diseases. In agriculture, we drive innovations that could nourish a growing population while restoring the planet.
It was founded in 2015 and headquartered in Leverkusen, Nordrhein-Westfalen.
Invests into
%20Ltd.jpeg)
Headquarters:
Leverkusen,Nordrhein-Westfalen,Germany,Europe
Employee Number:
11-50
Industry:
AI in HealthTech
Number Of Exists:
6
Investor Type:
Venture Funds
Founded Date:
2015-01-01
Funding Status:
private